Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G/A for BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value (DRUG).
- Disclosed ownership: 3%.
- Date of event: 31 Dec 2024.
Point72 Asset Management, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value (DRUG)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- DRUG
- Shares outstanding
- 4,506,300 shares
- Disclosed Ownership
- 135,189 shares
- Ownership
- 3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 16:06:27 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 3% ownership in BRIGHT MINDS BIOSCIENCES INC. Common Shares, without par value (DRUG) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 16:06.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 3% | 135,189 | 0 | 135,189 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 3% | 135,189 | 0 | 135,189 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 3% | 135,189 | 0 | 135,189 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |